bso cancer treatment glutathione Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced chemo-ferrotherapy via sustainable elimination | Journal of Nanobiotechnology Buthionine sulfoximine, an inhibitor of
Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF B and MAPK signaling pathways Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression ScienceDirect Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Glutathione content of cadmium or BSO treated cell organelles. Download Scientific Diagram Inhibiting glutathione synthesis sensitizes breast cancer cells to Download Scientific Diagram
Pay in 4 interest-free payments of $5.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





